Total Payments
$4,856
2024 Payments
$82.59
Companies
11
Transactions
51
Medicare Patients
247
Medicare Billing
$159,018
Payment Breakdown by Category
Other$2,750 (56.6%)
Food & Beverage$1,268 (26.1%)
Travel$547.26 (11.3%)
Education$290.19 (6.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $2,750 | 1 | 56.6% |
| Food and Beverage | $1,268 | 44 | 26.1% |
| Travel and Lodging | $547.26 | 3 | 11.3% |
| Education | $290.19 | 3 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $4,222 | 26 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $158.74 | 8 | $0 (2021) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $122.20 | 1 | $0 (2017) |
| Amgen Inc. | $100.10 | 5 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $77.72 | 4 | $0 (2022) |
| IDORSIA PHARMACEUTICALS US INC | $60.41 | 1 | $0 (2024) |
| Horizon Pharma plc | $37.39 | 2 | $0 (2017) |
| Mallinckrodt LLC | $25.15 | 1 | $0 (2018) |
| Boston Scientific Corporation | $24.97 | 1 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $16.06 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $82.59 | 2 | IDORSIA PHARMACEUTICALS US INC ($60.41) |
| 2023 | $22.07 | 1 | Fresenius USA Marketing, Inc. ($22.07) |
| 2022 | $43.09 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($28.04) |
| 2021 | $128.74 | 7 | AstraZeneca Pharmaceuticals LP ($62.56) |
| 2020 | $37.13 | 2 | AstraZeneca Pharmaceuticals LP ($37.13) |
| 2019 | $4,221 | 26 | Fresenius USA Marketing, Inc. ($4,080) |
| 2018 | $150.28 | 7 | Fresenius USA Marketing, Inc. ($66.48) |
| 2017 | $170.70 | 4 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($122.20) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Education | In-kind items and services | $60.41 | General |
| Category: Hypertension | ||||||
| 10/17/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Phosphate binder for ESRD | ||||||
| 06/29/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/17/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: Cardio-renal | ||||||
| 04/13/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Phosphate binder for ESRD | ||||||
| 09/23/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Cardio-renal | ||||||
| 09/09/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/25/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Cardio-renal | ||||||
| 08/11/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Cardio-renal | ||||||
| 07/26/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/15/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/16/2021 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Phosphate binder for ESRD | ||||||
| 02/13/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/09/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/18/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/12/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/25/2019 | Amgen Inc. | Parsabiv (Biological), Sensipar | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Nephrology | ||||||
| 11/20/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/28/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: NEPHROLOGY | ||||||
| 06/25/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Honoraria | Cash or cash equivalent | $2,750.00 | General |
| Category: Phosphate binder for ESRD | ||||||
| 06/25/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $276.86 | General |
| Category: Phosphate binder for ESRD | ||||||
| 06/25/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Travel and Lodging | Cash or cash equivalent | $276.60 | General |
| Category: Phosphate binder for ESRD | ||||||
| 06/25/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Education | In-kind items and services | $207.78 | General |
| Category: Phosphate binder for ESRD | ||||||
| 06/25/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Travel and Lodging | Cash or cash equivalent | $192.66 | General |
| Category: Phosphate binder for ESRD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 39 | 55 | $13,271 | $3,900 |
| 2022 | 3 | 55 | 176 | $55,664 | $37,710 |
| 2021 | 2 | 74 | 268 | $82,967 | $58,038 |
| 2020 | 3 | 79 | 274 | $83,698 | $59,370 |
Total Patients
247
Total Services
773
Medicare Billing
$159,018
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 20 | 29 | $8,222 | $2,513 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 19 | 26 | $5,049 | $1,387 | 27.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 13 | 123 | $43,050 | $33,771 | 78.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 18 | 23 | $6,637 | $2,071 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 24 | 30 | $5,977 | $1,867 | 31.2% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 22 | 178 | $62,300 | $49,678 | 79.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 35 | 57 | $16,542 | $5,363 | 32.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 33 | $4,125 | $2,998 | 72.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 23 | 204 | $71,400 | $54,399 | 76.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 26 | 29 | $6,765 | $2,219 | 32.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 18 | 29 | $3,733 | $2,209 | 59.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 12 | 12 | $1,800 | $543.29 | 30.2% |
About Dr. Eric Jerome, M.D
Dr. Eric Jerome, M.D is a Nephrology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841216330.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Jerome, M.D has received a total of $4,856 in payments from pharmaceutical and medical device companies, with $82.59 received in 2024. These payments were reported across 51 transactions from 11 companies. The most common payment nature is "Honoraria" ($2,750).
As a Medicare-enrolled provider, Jerome has provided services to 247 Medicare beneficiaries, totaling 773 services with total Medicare billing of $159,018. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Brooklyn, NY
- Active Since 07/15/2006
- Last Updated 09/18/2019
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1841216330
Products in Payments
- Velphoro (Drug) $4,129
- LOKELMA (Drug) $138.49
- TOLVAPTAN (Drug) $122.20
- Parsabiv (Biological) $100.10
- Kerendia (Drug) $77.72
- Tryvio (Drug) $60.41
- KRYSTEXXA (Drug) $37.39
- ACTHAR (Biological) $25.15
- WATCHMAN (Device) $24.97
- BRILINTA (Drug) $20.25
- JYNARQUE (Drug) $16.06
- ZEPATIER (Drug) $11.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Brooklyn
Gregg Miller, Md, MD
Nephrology — Payments: $57,485
Nephrology $57,485
Alla Maslova
Nephrology — Payments: $18,516
Nephrology $18,516
Li Yang, Md, MD
Nephrology — Payments: $17,726
Nephrology $17,726
Dr. Louis Carrera, Md, MD
Nephrology — Payments: $17,135
Nephrology $17,135
Dr. Mariana Markell, M.d, M.D
Nephrology — Payments: $15,506
Nephrology $15,506
Dr. Alan Nissenbaum, Md, MD
Nephrology — Payments: $15,228
Nephrology $15,228